Amarin Ends 'Skinny Label' Patent Case Against Hikma
Amarin Pharma Inc. is dropping its patent suit over Hikma Pharmaceuticals USA Inc.'s generic version of a heart drug that uses a so-called skinny label, months after the U.S. Supreme Court...To view the full article, register now.
Already a subscriber? Click here to view full article